The hematologic neoplasm systemic mastocytosis is marked by the clonal proliferation of mast cells in the skin, bone marrow, gastrointestinal tract, spleen, and/or liver, caused by an activating KIT mutation in the KIT gene.
/PRNewswire/ The gastric cancer drugs market size is expected to grow by USD 12.764 billion from 2022 to 2027. In addition, the momentum of the market will.
Eli Lilly & Co. on Tuesday reported positive results from a study evaluating its targeted therapy Retevmo versus the current standard initial treatments for.
Needham slightly increased the price target for Blueprint Medicines Corp BPMC from $65 to $66 with a Buy rating. The analysts Ami Fadia and Eason Lee note a…